NCT02815644View on ClinicalTrials.gov

Empa/Lina FDC Food Effect Study (Japan)

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 15, 2016

Primary Completion Date

October 5, 2016

Study Completion Date

October 5, 2016

Conditions
Healthy
Interventions
DRUG

empagliflozin/linagliptin FDC

empagliflozin/linagliptin fixed-dose combination (FDC) film-coated tablet

Trial Locations (1)

133-0004

SOUSEIKAI Sumida Hospital, Tokyo, Sumida-ku

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY